Treatment of recurrent malignant glioma with G207, a genetically engineered herpes simplex virus-1, followed by irradiation: Phase I study results
Year: 2009
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: University of Alabama at Birmingham
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2226519237
